Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Zimmer Biomet (ZBH) to $107 from $115 and keeps a Hold rating on the ...
Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...
The S&P 500 Dividend Aristocrats Index pairs long-term results with versatility. We sell different types of products and services to both investment professionals and individual investors. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results